India's patent power casts new shadow over drug pricing
Pharmaceutical companies in India could face greater pressure to cut prices, expand patient-assistance programs or negotiate voluntary licenses after a court clarified that the government can authorize the use of patented...To view the full article, register now.
Already a subscriber? Click here to view full article